Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Drug development"" wg kryterium: Temat


Tytuł :
A Proposal to Increase Value and Equity in the Development and Distribution of New Pharmaceuticals.
Autorzy :
Sorum P; Internal Medicine and Pediatrics, 1092Albany Medical College, Albany Medical Center Internal Medicine and Pediatrics, Cohoes, NY, USA.
Stein C; Management and Health Studies, Siena College, Loudonville, NY, USA.
Wales D; Internal Medicine and Pediatrics, 1092Albany Medical College, Albany Medical Center Internal Medicine and Pediatrics, Cohoes, NY, USA.
Pratt D; 167519Schenectady County Public Health Services, Schenectady, NY, USA.
Pokaż więcej
Źródło :
International journal of health services : planning, administration, evaluation [Int J Health Serv] 2022 Jul; Vol. 52 (3), pp. 363-371. Date of Electronic Publication: 2022 May 12.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Development*/legislation & jurisprudence
Drug Development*/organization & administration
Drug Industry*
United States Food and Drug Administration*
COVID-19 Vaccines ; Humans ; Marketing ; Pharmaceutical Preparations ; United States
Czasopismo naukowe
Tytuł :
Success rates for US and Canadian anticancer drug development efforts in pediatric oncology.
Autorzy :
Oliviero E; Biomedical Ethics Unit, McGill University, Montreal, Quebec, Canada.
Kourkopoulos G; Biomedical Ethics Unit, McGill University, Montreal, Quebec, Canada.
Kimmelman J; Biomedical Ethics Unit, McGill University, Montreal, Quebec, Canada.
Pokaż więcej
Źródło :
Pediatric blood & cancer [Pediatr Blood Cancer] 2022 Aug; Vol. 69 (8), pp. e29534. Date of Electronic Publication: 2022 Jan 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents*/therapeutic use
Drug Development*
Neoplasms*/drug therapy
Canada ; Child ; Drug Approval ; Humans ; Medical Oncology ; Pediatrics ; United States ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł :
Rational and practical considerations to guide a target product profile for patient-centric drug product development with measurable patient outcomes - A proposed roadmap.
Autorzy :
Stegemann S; Institute for Process and Particle Engineering, Graz University of Technology, Inffeldgasse 13, 8010 Graz, Austria. Electronic address: .
Sheehan L; SRL, Office of Technology 2-44, Western Gateway Building, University College Cork, Ireland. Electronic address: .
Rossi A; Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy. Electronic address: .
Barrett A; Drug Product Design, Pharmaceutical Sciences, Pfizer, Discovery Park House, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK. Electronic address: .
Paudel A; Institute for Process and Particle Engineering, Graz University of Technology, Inffeldgasse 13, 8010 Graz, Austria; Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria. Electronic address: .
Crean A; SSPC Pharmaceutical Research Centre, School of Pharmacy, University College Cork, Cork, Ireland. Electronic address: .
Ruiz F; ClinSearch, 110 Avenue, Pierre Brossolette, 92240 Malakoff, France. Electronic address: .
Bresciani M; CMAC Technology and Innovation Centre, University of Strathclyde, 99 George Street, Glasgow G1 1RD, UK. Electronic address: .
Liu F; Department of Clinical, Pharmaceutical and Biological Sciences, University of Hertfordshire, College Lane, Hatfield AL10 9AB, UK. Electronic address: .
Shariff Z; School of Pharmacy, Aston University, Birmingham, B4 7ET, UK. Electronic address: .
Shine M; SRL, Office of Technology 2-44, Western Gateway Building, University College Cork, Ireland. Electronic address: .
Schmelzer C; Welfenstrasse 14, D-55218 Ingelheim, Germany. Electronic address: .
Pense-Lheritier AM; Ecole de Biologie Industrielle, 49 avenue des Genottes, 95895 Cergy Cedex, France. Electronic address: .
Pokaż więcej
Źródło :
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2022 Aug; Vol. 177, pp. 81-88. Date of Electronic Publication: 2022 Jun 17.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Design*
Drug Development*
Aged ; Child ; Humans ; Patient-Centered Care
Czasopismo naukowe
Tytuł :
Review: Role of Model-Informed Drug Development Approaches in the Lifecycle of Drug Development and Regulatory Decision-Making.
Autorzy :
Madabushi R; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA. .
Seo P; Division of Biopharmaceutics, Office of New Drug Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Zhao L; Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Tegenge M; Division of Clinical Evaluation and Pharmacology/Toxicology, Office of Tissue and Advanced Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Zhu H; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA. .
Pokaż więcej
Źródło :
Pharmaceutical research [Pharm Res] 2022 Aug; Vol. 39 (8), pp. 1669-1680. Date of Electronic Publication: 2022 May 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Development*
Drugs, Generic*
Animals ; Drug Approval ; Humans ; Life Cycle Stages ; Pharmaceutical Preparations ; United States ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł :
Quality Assurance of PBPK Modeling Platforms and Guidance on Building, Evaluating, Verifying and Applying PBPK Models Prudently under the Umbrella of Qualification: Why, When, What, How and By Whom?
Autorzy :
Frechen S; Bayer AG, Pharmaceuticals, Research & Development, Systems Pharmacology & Medicine, Leverkusen, 51368, Germany. .
Rostami-Hodjegan A; Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK.; Certara UK Limited (Simcyp Division), Sheffield, UK.
Pokaż więcej
Źródło :
Pharmaceutical research [Pharm Res] 2022 Aug; Vol. 39 (8), pp. 1733-1748. Date of Electronic Publication: 2022 Apr 20.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Development*
Models, Biological*
Algorithms ; Computer Simulation ; Pharmacokinetics ; Software
Czasopismo naukowe
Tytuł :
Role of Disease Progression Models in Drug Development.
Autorzy :
Barrett JS; Rare Disease Cures Accelerator Data Analytics Platform, Critical Path Institute, Tuscon, AZ, 85718, USA. .
Nicholas T; Global Product Development, Pfizer Inc, 445 Eastern Point Rd, Groton, CT, 06340, USA.
Azer K; Axcella Therapeutics, 840 Memorial Drive, Cambridge, MA, 02139, USA.
Corrigan BW; Global Product Development, Pfizer Inc, 445 Eastern Point Rd, Groton, CT, 06340, USA.
Pokaż więcej
Źródło :
Pharmaceutical research [Pharm Res] 2022 Aug; Vol. 39 (8), pp. 1803-1815. Date of Electronic Publication: 2022 Apr 11.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Disease Progression*
Drug Development*
Clinical Trials as Topic ; Humans ; Research Design
Czasopismo naukowe
Tytuł :
BETA: a comprehensive benchmark for computational drug-target prediction.
Autorzy :
Zong N; Department of Artificial Intelligence and Informatics Research, Mayo Clinic, Rochester, MN.
Li N; Center for Structure Biology, Center for Cancer Research, National Cancer Institute, Frederick, MD.
Wen A; Department of Artificial Intelligence and Informatics Research, Mayo Clinic, Rochester, MN.
Ngo V; Betty Irene Moore School of Nursing, University of California Davis Health, Sacramento, CA.; Stanford Health Policy, Stanford School of Medicine and Freeman Spogli Institute for International Studies, Palo Alto, CA.
Yu Y; Department of Artificial Intelligence and Informatics Research, Mayo Clinic, Rochester, MN.
Huang M; Department of Artificial Intelligence and Informatics Research, Mayo Clinic, Rochester, MN.
Chowdhury S; Department of Artificial Intelligence and Informatics Research, Mayo Clinic, Rochester, MN.
Jiang C; Department of Computer Science and Software Engineering, Auburn University, Auburn, AL.
Fu S; Department of Artificial Intelligence and Informatics Research, Mayo Clinic, Rochester, MN.
Weinshilboum R; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN.
Jiang G; Department of Artificial Intelligence and Informatics Research, Mayo Clinic, Rochester, MN.
Hunter L; Department of Pharmacology, University of Colorado Denver, Aurora, CO.
Liu H; Department of Artificial Intelligence and Informatics Research, Mayo Clinic, Rochester, MN.
Pokaż więcej
Źródło :
Briefings in bioinformatics [Brief Bioinform] 2022 Jul 18; Vol. 23 (4).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Benchmarking*
Drug Development*
Algorithms ; Drug Evaluation, Preclinical ; Drug Repositioning/methods ; Proteins/genetics
Czasopismo naukowe
Tytuł :
The Food and Drug Administration's Role in Dermatologic Drug Development.
Autorzy :
Lewis FS; Division of Dermatology and Dentistry, Office of Inflammation and Immunology, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, WO22, 10903 New Hampshire Avenue, Silver Spring, MD 20993-0002, USA. Electronic address: .
Marcus KA; Division of Dermatology and Dentistry, Office of Inflammation and Immunology, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, WO22, 10903 New Hampshire Avenue, Silver Spring, MD 20993-0002, USA.
Pokaż więcej
Źródło :
Dermatologic clinics [Dermatol Clin] 2022 Jul; Vol. 40 (3), pp. 249-263.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Approval*
Drug Development*
Allergens ; Humans ; Pharmaceutical Preparations ; United States ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł :
Multi-scaled self-attention for drug-target interaction prediction based on multi-granularity representation.
Autorzy :
Zeng Y; School of Information Science and Technology, Zhejiang Sci-Tech University, Hangzhou, China.
Chen X; College of Computer Science, Sichuan University, Chengdu, China.
Peng D; College of Computer Science, Sichuan University, Chengdu, China.; Shenzhen Peng Cheng Laboratory, Shenzhen, China.; Chengdu Sobey Digital Technology Co., Ltd, Chengdu, China.
Zhang L; Sichuan Zhiqian Technology Co., Ltd, Chengdu, China.; Chengdu Ruibei Yingte Information Technology Co., Ltd, Chengdu, China.
Huang H; Sichuan Provincial Commission of Politics and Law, Chengdu, China. .
Pokaż więcej
Źródło :
BMC bioinformatics [BMC Bioinformatics] 2022 Aug 03; Vol. 23 (1), pp. 314. Date of Electronic Publication: 2022 Aug 03.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Development*
Proteins*/metabolism
Amino Acid Sequence ; Attention ; Drug Discovery/methods
Czasopismo naukowe
Tytuł :
Reciprocal perspective as a super learner improves drug-target interaction prediction (MUSDTI).
Autorzy :
Dick K; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada. .; Institute of Data Science, Carleton University, Ottawa, ON, Canada. .
Kyrollos DG; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.; Institute of Data Science, Carleton University, Ottawa, ON, Canada.
Cosoreanu ED; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Dooley J; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Fryer JS; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Gordon SM; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Kharbanda N; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Klamrowski M; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
LaCasse PNL; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Leung TF; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Nasir MA; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Qiu C; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Robinson AS; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Shao D; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Siromahov BR; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Starlight E; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Tran C; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Wang C; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Yang YK; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Green JR; Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.; Institute of Data Science, Carleton University, Ottawa, ON, Canada.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2022 Aug 02; Vol. 12 (1), pp. 13237. Date of Electronic Publication: 2022 Aug 02.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Development*
Drug Discovery*/methods
Computer Simulation ; Drug Interactions ; Humans ; Machine Learning
Czasopismo naukowe
Tytuł :
Applications of Model Informed Drug Development (MIDD) in Drug Development Lifecycle and Regulatory Review.
Autorzy :
Mitra A; Clinical Pharmacology and Pharmacometrics, Janssen R&D, Spring House, PA, USA. .; Clinical Pharmacology, Kura Oncology, San Diego, CA, USA. .
Wang Y; Createrna Science and Technology, Wuhan, China. .
Pokaż więcej
Źródło :
Pharmaceutical research [Pharm Res] 2022 Aug; Vol. 39 (8), pp. 1663-1667. Date of Electronic Publication: 2022 Jul 05.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Development*
Czasopismo naukowe
Tytuł :
A long-acting C-natriuretic peptide for achondroplasia.
Autorzy :
Schneider EL; ProLynx, San Francisco, CA 94158.
Carreras CW; ProLynx, San Francisco, CA 94158.
Reid R; ProLynx, San Francisco, CA 94158.
Ashley GW; ProLynx, San Francisco, CA 94158.
Santi DV; ProLynx, San Francisco, CA 94158.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Jul 26; Vol. 119 (30), pp. e2201067119. Date of Electronic Publication: 2022 Jul 18.
Typ publikacji :
Journal Article
MeSH Terms :
Achondroplasia*/drug therapy
Drug Development*
Natriuretic Peptide, C-Type*/administration & dosage
Natriuretic Peptide, C-Type*/analogs & derivatives
Natriuretic Peptide, C-Type*/chemical synthesis
Natriuretic Peptide, C-Type*/pharmacokinetics
Animals ; Child ; Delayed-Action Preparations ; Humans ; Hydrogels/chemistry ; Injections, Subcutaneous ; Mice ; Microspheres
Czasopismo naukowe
Tytuł :
AttentionSiteDTI: an interpretable graph-based model for drug-target interaction prediction using NLP sentence-level relation classification.
Autorzy :
Yazdani-Jahromi M; Industrial Engineering and Management Systems, University of Central Florida, Street, 32816, 4000 Central Florida Blvd. Orlando, USA.
Yousefi N; Industrial Engineering and Management Systems, University of Central Florida, Street, 32816, 4000 Central Florida Blvd. Orlando, USA.
Tayebi A; Industrial Engineering and Management Systems, University of Central Florida, Street, 32816, 4000 Central Florida Blvd. Orlando, USA.
Kolanthai E; College of Medicine, Bionix Cluster, University of Central Florida, 4000 Central Florida Blvd. Orlando, 32816, Florida, USA.
Neal CJ; College of Medicine, Bionix Cluster, University of Central Florida, 4000 Central Florida Blvd. Orlando, 32816, Florida, USA.
Seal S; College of Medicine, Bionix Cluster, University of Central Florida, 4000 Central Florida Blvd. Orlando, 32816, Florida, USA.; Advanced Materials Processing and Analysis Center, Dept. of Materials Science and Engineering, University of Central Florida, 4000 Central Florida Blvd. Orlando, 32816, Florida, USA.
Garibay OO; Industrial Engineering and Management Systems, University of Central Florida, Street, 32816, 4000 Central Florida Blvd. Orlando, USA.
Pokaż więcej
Źródło :
Briefings in bioinformatics [Brief Bioinform] 2022 Jul 18; Vol. 23 (4).
Typ publikacji :
Journal Article
MeSH Terms :
Drug Development*
Natural Language Processing*
Drug Repositioning ; Protein Binding ; Proteins/chemistry
Czasopismo naukowe
Tytuł :
Mitigating cold-start problems in drug-target affinity prediction with interaction knowledge transferring.
Autorzy :
Nguyen TM; Applied Artificial Intelligence Institute, Deakin University, Victoria, Australia.
Nguyen T; Applied Artificial Intelligence Institute, Deakin University, Victoria, Australia.
Tran T; Applied Artificial Intelligence Institute, Deakin University, Victoria, Australia.
Pokaż więcej
Źródło :
Briefings in bioinformatics [Brief Bioinform] 2022 Jul 18; Vol. 23 (4).
Typ publikacji :
Journal Article
MeSH Terms :
Drug Development*
Machine Learning*
Drug Discovery/methods ; Drug Repositioning
Czasopismo naukowe
Tytuł :
Pediatric Extrapolation of Adult Efficacy to Children Is Critical for Efficient and Successful Drug Development.
Autorzy :
Mulberg AE; University of Maryland School of Medicine, Baltimore, Maryland; Janssen; and Barts and the London School of Medicine and Dentistry. Electronic address: .
Conklin LS; University of Maryland School of Medicine, Baltimore, Maryland; Janssen; and Barts and the London School of Medicine and Dentistry.
Croft NM; University of Maryland School of Medicine, Baltimore, Maryland; Janssen; and Barts and the London School of Medicine and Dentistry.
Pokaż więcej
Corporate Authors :
I-ACT for Children Pediatric Extrapolation Working Group; University of Maryland School of Medicine, Baltimore, Maryland; Janssen; and Barts and the London School of Medicine and Dentistry.
Źródło :
Gastroenterology [Gastroenterology] 2022 Jul; Vol. 163 (1), pp. 77-83. Date of Electronic Publication: 2022 Mar 12.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Development*
Adult ; Age Factors ; Child ; Humans ; United States ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł :
The Degradation Map Process - A Tool for Obtaining a Lean Stability Strategy in Drug Development.
Autorzy :
Träff AM; Advanced Drug Delivery, Pharmaceutical Sciences, Bio Pharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Ottosson J; Advanced Drug Delivery, Pharmaceutical Sciences, Bio Pharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Andersson T; New Modalities Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden. Electronic address: .
Pokaż więcej
Źródło :
Journal of pharmaceutical sciences [J Pharm Sci] 2022 Jul; Vol. 111 (7), pp. 1918-1925. Date of Electronic Publication: 2021 Dec 18.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Development*
Drug Industry*
Drug Stability
Czasopismo naukowe
Tytuł :
Biomarker Qualification at the European Medicines Agency: A Review of Biomarker Qualification Procedures From 2008 to 2020.
Autorzy :
Bakker E; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Hendrikse NM; European Medicines Agency, Amsterdam, The Netherlands.
Ehmann F; European Medicines Agency, Amsterdam, The Netherlands.
van der Meer DS; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.; College ter Beoordeling van Geneesmiddelen-Medicines Evaluation Board, Utrecht, The Netherlands.
Llinares Garcia J; European Medicines Agency, Amsterdam, The Netherlands.
Vetter T; European Medicines Agency, Amsterdam, The Netherlands.
Starokozhko V; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.; College ter Beoordeling van Geneesmiddelen-Medicines Evaluation Board, Utrecht, The Netherlands.
Mol PGM; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.; College ter Beoordeling van Geneesmiddelen-Medicines Evaluation Board, Utrecht, The Netherlands.; Scientific Advice Working Party, European Medicines Agency, Amsterdam, The Netherlands.
Pokaż więcej
Źródło :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Jul; Vol. 112 (1), pp. 69-80. Date of Electronic Publication: 2022 Mar 05.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Development*
Precision Medicine*
Biomarkers ; Humans
Czasopismo naukowe
Tytuł :
Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target.
Autorzy :
Zahoor I; Department of Neurology, Henry Ford Health System, Detroit, MI 48202.
Suhail H; Department of Neurology, Henry Ford Health System, Detroit, MI 48202.
Datta I; Department of Public Health Sciences, Henry Ford Health System, Detroit, MI 48202.
Ahmed ME; Department of Neurology, Henry Ford Health System, Detroit, MI 48202.
Poisson LM; Department of Public Health Sciences, Henry Ford Health System, Detroit, MI 48202.
Waters J; Department of Neurology, Henry Ford Health System, Detroit, MI 48202.
Rashid F; Department of Neurology, Henry Ford Health System, Detroit, MI 48202.
Bin R; Department of Neurology, Henry Ford Health System, Detroit, MI 48202.
Singh J; Department of Neurology, Henry Ford Health System, Detroit, MI 48202.
Cerghet M; Department of Neurology, Henry Ford Health System, Detroit, MI 48202.
Kumar A; Department of Anatomy and Cell Biology, School of Medicine, Wayne State University, Detroit, MI 48202.
Hoda MN; Department of Neurology, Henry Ford Health System, Detroit, MI 48202.
Rattan R; Women's Health Services, Henry Ford Health System, Detroit, MI 48202.
Mangalam AK; Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA 5224.
Giri S; Department of Neurology, Henry Ford Health System, Detroit, MI 48202.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Jun 21; Vol. 119 (25), pp. e2123265119. Date of Electronic Publication: 2022 Jun 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms :
Drug Development*/methods
Glycolysis*/drug effects
Metabolomics*
Multiple Sclerosis, Relapsing-Remitting*/blood
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/metabolism
Animals ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use ; Antimetabolites/pharmacology ; Antimetabolites/therapeutic use ; Deoxyglucose/pharmacology ; Deoxyglucose/therapeutic use ; Encephalomyelitis, Autoimmune, Experimental/drug therapy ; Encephalomyelitis, Autoimmune, Experimental/metabolism ; Humans ; Leukocytes, Mononuclear/metabolism ; Mice
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies